ICON to acquire PRA Health Sciences in $12b deal
WEBFeb 25, 2021 · ICON, a Dublin-based contract research organization (CRO) has entered into an agreement to acquire PRA Health Sciences, another CRO currently sited in Raleigh, North Carolina. The arrangement comprises a cash and stock transaction valued at approximately $12bn USD. According to company leaders, the transaction stands to benefit pharmaceutical ...
Premier Research: holistic approach benefits development
WEBOct 6, 2020 · Holistic design starts off with designing a target product profile that considers the end goal early in the development planning. Also, part of a successful holistic approach, Sharif suggested, is asking thoughtful, appropriate questions at the outset, making sure to consider outcome-focused impactful issues at every stage of development.
Ukraine war dramatically impacting global clinical development
WEBMar 24, 2022 · Clinical tech services company Phesi has released a report showing the extent of the impact of the war in Ukraine on clinical development. The report takes a look at “pivotal” trials sponsored by pharmaceutical companies that represent the most critical global clinical development activities. According to the findings, as of March 16, 2022 ...
$680M deal with CBC and Mubadala shifts UCB's strategy
WEBAug 29, 2024 · The $680 million transaction, announced on August 26, involves the sale of established brands such as Keppra, Vimpat, Neupro, Zyrtec, and Xyzal, along with UCB's Zhuhai manufacturing site, to CBC Group and Mubadala Investment Company. This deal marks a pivotal moment in UCB’s evolution, as the company shifts its focus towards innovation and ...
The rise of the integrated research organization: A conversation …
WEBSep 11, 2019 · Behind the term is NC-based Javara, which made its official debut in June 2018 . The company’s CEO Jennifer Byrne told us the name ‘integrated research organization,’ or IRO, emerged as the descriptor for the new clinical research model following discussions with Wake Forest Baptist Health.
McKesson completes RxCrossroads acquisition
WEBJan 8, 2018 · McKesson Corporation has completed its acquisition of RxCrossroads to support customer needs beyond channel distribution as the industry faces increasing challenges. The supply chain management solutions company purchased RxCrossroads – a Kentucky-based specialty solutions provider – from CVS Health Corporation in a deal valued at $735m ...
Streamlining healthcare supply chains: TraceLink teams up with …
WEBAug 14, 2024 · By integrating our multi-enterprise digital network platform with Tecsys' robust inventory and warehouse management functionality, we can provide real-time supply chain information that enhances patient care while reducing administrative burdens.”. For TraceLink, this collaboration is more than just a tactical move—it aligns with the ...
Highlight 1 study to test fezolinetant in women with breast cancer
WEBAug 27, 2024 · The Highlight 1 study is a randomized, placebo-controlled, double-blind phase 3 clinical trial designed to evaluate the efficacy and safety of fezolinetant for the treatment of moderate to severe VMS in women with stage 0 to 3 hormone receptor-positive breast cancer receiving adjuvant endocrine therapy. Approximately 540 participants are ...
Growing mini trees - exploring QS-21, the vaccine adjuvant
WEBApr 17, 2024 · Known for its potential in boosting vaccine effectiveness, QS-21 contains water-soluble triterpene glycosides, a type of compound called saponins, which are believed to enhance both humoral and cell-mediated immunity. During the discussion the significance of QS-21 as a vaccine adjuvant and its implications for …
Blood-based Alzheimer’s test set to revolutionize early diagnosis
WEBAug 27, 2024 · The collaboration between ALZpath and Beckman Coulter marks a significant step toward making early detection more accessible and less invasive. The introduction of a blood-based diagnostic test, featuring ALZpath’s novel pTau217 antibody, could transform how Alzheimer’s is diagnosed and …